SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950144-04-001277
Filing Date
2004-02-13
Accepted
2004-02-13 16:17:54
Documents
2
Group Members
PHARMABIO DEVELOPMENT INC.QFINANCE, INC.

Document Format Files

Seq Description Document Type Size
1 THE MEDICINES COMPANY g87208esc13gza.htm SC 13G/A 33853
3 EX-99.01-JOINT FILING AGREEMENT g87208eexv99w01.htm EX-99.01 7910
  Complete submission text file 0000950144-04-001277.txt   44061
Mailing Address 4709 CREEKSTONE DR STE 300 DURHAM NC 27703-8411
Business Address 4709 CREEKSTONE DR RIVERBIRCH BLDG STE 200 DURHAM NC 27703-8411 9199982000
QUINTILES TRANSNATIONAL CORP (Filed by) CIK: 0000919623 (see all company filings)

IRS No.: 561714315 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address
Business Address 8 CAMPUS DRIVE PARSIPPANY NJ 07054 973-656-1616
MEDICINES CO /DE (Subject) CIK: 0001113481 (see all company filings)

IRS No.: 043324394 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60201 | Film No.: 04599372
SIC: 2834 Pharmaceutical Preparations